Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India

Fig 3 and Fig 4 are incorrect. The authors have provided corrected versions here.

Fig 3. Scatter plot showing parasite load at the pre-treatment stage in the cases that eventually relapsed vs those that remained cured.

Parasite load was determined by Q-PCR in slit aspirate sample at the time of diagnosis of PKDL and expressed as the number of Leishmania parasite/μl slit aspirate. P value was calculated using Mann-Whitney test. Horizontal bars indicate mean± SEM.

Fig 4. In vitro MIL susceptibility of parasite isolates from cured (n = 7) and relapsed (n = 6) PKDL patients.

MIL susceptibility at (A) promastigote stage (B) amastigote stage. Each individual value represents mean IC₅₀± SD of the results from two separate assays. P value was calculated using Mann-Whitney test. Horizontal bars indicate mean ±SEM